PDCD1 and cancer: That PD-L1 expression is likely an adaptive response in HPV-positive tumors is further supported by the close proximity of PD-L1+ TAM and cancer cells to PD-1+ CTL, which may reflect a potentially active host immunological response otherwise blocked by immune checkpoint interactions.